-
Table of Contents
Fasted vs Fed State Administration of Drostanolone Propionato
Drostanolone propionato, also known as Masteron, is a synthetic anabolic androgenic steroid (AAS) that has been used in the world of sports for its performance-enhancing effects. It is commonly used by bodybuilders and athletes to increase muscle mass, strength, and endurance. However, there has been much debate about the optimal timing of administration of drostanolone propionato – whether it should be taken in a fasted or fed state. In this article, we will explore the pharmacokinetics and pharmacodynamics of drostanolone propionato and discuss the potential benefits and drawbacks of administering it in a fasted or fed state.
Pharmacokinetics of Drostanolone Propionato
Before delving into the effects of fasted vs fed state administration, it is important to understand the pharmacokinetics of drostanolone propionato. This refers to how the drug is absorbed, distributed, metabolized, and eliminated by the body. Drostanolone propionato is a synthetic derivative of dihydrotestosterone (DHT) and has a half-life of approximately 2-3 days (Schänzer et al. 1996). This means that it takes 2-3 days for half of the drug to be eliminated from the body.
When administered orally, drostanolone propionato is rapidly metabolized by the liver, resulting in low bioavailability. This is why it is commonly administered via intramuscular injection, which bypasses the liver and allows for higher bioavailability. Once in the bloodstream, drostanolone propionato binds to androgen receptors in various tissues, including muscle, bone, and the central nervous system (CNS). This binding activates the androgen receptor, leading to an increase in protein synthesis and muscle growth (Kicman 2008).
Pharmacodynamics of Drostanolone Propionato
The pharmacodynamics of drostanolone propionato refer to its effects on the body. As mentioned earlier, it binds to androgen receptors, leading to an increase in protein synthesis and muscle growth. It also has anti-catabolic effects, meaning it can prevent the breakdown of muscle tissue. This is why it is commonly used during cutting cycles, where the goal is to maintain muscle mass while reducing body fat.
In addition to its anabolic effects, drostanolone propionato also has androgenic effects, which can lead to side effects such as acne, hair loss, and increased aggression. These effects are dose-dependent and can be managed by carefully monitoring the dosage and duration of use (Kicman 2008).
Fasted State Administration
Now, let’s discuss the potential benefits and drawbacks of administering drostanolone propionato in a fasted state. Fasting refers to abstaining from food and drink for a certain period of time. Some athletes and bodybuilders believe that taking drostanolone propionato in a fasted state can enhance its effects. This is based on the idea that fasting can increase growth hormone levels, which can in turn increase muscle growth and fat loss (Hartman et al. 1992).
However, there is limited research on the effects of fasting on AAS administration. One study found that fasting for 24 hours before administering testosterone enanthate (another AAS) did not significantly affect its pharmacokinetics or pharmacodynamics (Kicman et al. 1995). This suggests that fasting may not have a significant impact on the absorption and effects of drostanolone propionato.
On the other hand, fasting can potentially lead to low blood sugar levels, which can cause dizziness, weakness, and fatigue. This can be especially dangerous for athletes who engage in intense training while fasting. Additionally, fasting can also lead to a decrease in insulin levels, which can affect the body’s ability to build and repair muscle tissue (Hartman et al. 1992). Therefore, it is important to carefully consider the potential risks before administering drostanolone propionato in a fasted state.
Fed State Administration
Now, let’s explore the potential benefits and drawbacks of administering drostanolone propionato in a fed state. Fed state refers to a state where the body has recently consumed food and has high levels of nutrients and insulin in the bloodstream. Some athletes and bodybuilders believe that taking drostanolone propionato in a fed state can enhance its effects by providing the body with the necessary nutrients for muscle growth and repair.
However, there is limited research on the effects of fed state administration of AAS. One study found that administering testosterone enanthate after a high-fat meal resulted in a slight decrease in its bioavailability (Kicman et al. 1995). This suggests that consuming a high-fat meal before administering drostanolone propionato may decrease its effectiveness. However, more research is needed to fully understand the impact of fed state administration on the pharmacokinetics and pharmacodynamics of drostanolone propionato.
Another potential drawback of administering drostanolone propionato in a fed state is the potential for increased side effects. As mentioned earlier, drostanolone propionato has androgenic effects, which can be exacerbated by high levels of insulin and other growth factors in the bloodstream. This can lead to an increase in side effects such as acne and hair loss (Kicman 2008).
Expert Opinion
Based on the limited research available, it is difficult to determine whether fasted or fed state administration of drostanolone propionato is more beneficial. However, it is important to consider the potential risks and drawbacks of each approach. Fasting may not have a significant impact on the absorption and effects of drostanolone propionato, but it can potentially lead to low blood sugar levels and decreased insulin levels, which can affect muscle growth and repair. On the other hand, administering drostanolone propionato in a fed state may provide the necessary nutrients for muscle growth, but it may also increase the risk of side effects.
Ultimately, the decision to administer drostanolone propionato in a fasted or fed state should be based on individual preferences and goals. It is important to carefully consider the potential risks and benefits and to consult with a healthcare professional before making any changes to your AAS administration regimen.
References
Hartman, M.L., Clayton, P.E., Johnson, M.L., Celniker, A., Perlman, A.J., Alberti, K.G., & Thorner, M.O. (1992). A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. The Journal of Clinical Investigation, 90(5), 183